© Reuters. Vials labeled "Astra Zeneca COVID-19 Coronavirus Vaccine" and a syringe can be seen in front of a displayed AstraZeneca logo in this illustration photo
AMSTERDAM (Reuters) – As a precautionary measure, the Netherlands will stop using AstraZeneca's (NASDAQ 🙂 COVID-19 vaccine until at least March 29, the Dutch government announced on Sunday.
The move, which follows a similar decision by Ireland earlier in the day, is based on reports from Denmark and Norway of possible serious side effects, the government said.
Three health workers in Norway who recently received Thevaccine were being treated in the hospital for bleeding, blood clots and low platelet counts, health officials said on Saturday.
The Dutch Ministry of Health said in a statement that no such cases have been found in the Netherlands. There is still no evidence of a direct link between the vaccine and the reports from Denmark and Norway.
The government said it will now await an investigation by the European Medicines Agency (EMA).
"We cannot leave any doubts about the vaccine," said Dutch Health Minister Hugo de Jonge.
"We have to make sure everything is okay, so it is advisable to take a break for now."
The Dutch said late last week there was no reason to stop using the vaccine after blood clots were reported to have formed in some people injected with the vaccine.
The EMA and the World Health Organization have indicated that there is no evidence that these events were caused by vaccination, and AstraZeneca has also indicated that there was no evidence of an increased risk of deep vein thrombosis.
Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. As a result, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.
Fusion Media or any person involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.